Thirty-day results from prospective multi-specialty evaluation of carotid artery stenting using the CGuard MicroNet-covered Embolic Prevention System in real-world multicentre clinical practice: the IRON-Guard study
EuroIntervention 2018;13:1714-1720 published online May 2017. DOI: 10.4244/EIJ-D-17-00008
Francesco Speziale1, MD; Laura Capoccia1*, MD; Pasqualino Sirignano1, MD; Wassim Mansour1, MD; Chiara Pranteda1, MD; Renato Casana2, MD; Carlo Setacci3, MD; Federico Accrocca4, MD; Domenico Alberti5, MD; Gianmarco de Donato3, MD; Michelangelo Ferri6, MD; Andrea Gaggiano7, MD; Giuseppe Galzerano3, MD; Arnaldo Ippoliti8, MD; Nicola Mangialardi9, MD; Giovanni Pratesi8, MD; Sonia Ronchey9, MD; Maria Antonella Ruffino10, MD; Andrea Siani4
1. Vascular and Endovascular Surgery Division, Department of Surgery “Paride Stefanini”, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy; 2. Vascular and Endovascular Surgery Unit, Istituto Auxologico IRCCS, Milan, Italy; 3. Vascular and
Aims: The aim of the present study was to evaluate periprocedural and 30-day outcomes in a prospective series of patients treated with the CGuard Embolic Prevention System (EPS).
